BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 33219484)

  • 1. Mutation profile differences in younger and older patients with advanced breast cancer using circulating tumor DNA (ctDNA).
    Clifton K; Luo J; Tao Y; Saam J; Rich T; Roshal A; Frith A; Rigden C; Ademuyiwa F; Weilbaecher K; Hernandez-Aya L; Peterson LL; Bagegni N; Suresh R; Bose R; Opyrchal M; Wildes TM; Ma C
    Breast Cancer Res Treat; 2021 Feb; 185(3):639-646. PubMed ID: 33219484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of AR Alterations in Circulating Tumor DNA from Patients with Advanced Prostate Cancer.
    Ledet EM; Lilly MB; Sonpavde G; Lin E; Nussenzveig RH; Barata PC; Yandell M; Nagy RJ; Kiedrowski L; Agarwal N; Sartor O
    Oncologist; 2020 Apr; 25(4):327-333. PubMed ID: 32297439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid Capture-based Genomic Profiling of Circulating Tumor DNA From Patients With Advanced Ovarian
    Shen W; Shan B; Liang S; Zhang J; Yu Y; Zhang Y; Wang G; Bai Y; Qian B; Lu J; Jiang Z
    Pathol Oncol Res; 2021; 27():581534. PubMed ID: 34257528
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay.
    Hsiehchen D; Espinoza M; Gerber DE; Beg MS
    Cancer Biol Ther; 2021 Sep; 22(7-9):455-464. PubMed ID: 34392779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational Signature Changes in Patients With Metastatic Squamous Cell Carcinoma of the Anal Canal.
    LaPelusa M; Cann C; Ciombor KK; Eng C
    Oncologist; 2024 Apr; 29(4):e475-e486. PubMed ID: 38103030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating the complexity of post-NAT therapy in breast cancer: The role of ctDNA testing.
    Abahssain H; Souadka A
    J Surg Oncol; 2024 Apr; ():. PubMed ID: 38652512
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival.
    Magbanua MJM; Swigart LB; Wu HT; Hirst GL; Yau C; Wolf DM; Tin A; Salari R; Shchegrova S; Pawar H; Delson AL; DeMichele A; Liu MC; Chien AJ; Tripathy D; Asare S; Lin CJ; Billings P; Aleshin A; Sethi H; Louie M; Zimmermann B; Esserman LJ; van 't Veer LJ
    Ann Oncol; 2021 Feb; 32(2):229-239. PubMed ID: 33232761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and Diagnostic Utilization of Cellular and Cell-Free Tumor DNA.
    Dudley JC; Diehn M
    Annu Rev Pathol; 2021 Jan; 16():199-222. PubMed ID: 33228464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Isolation of Circulating Nucleic Acids and EV-Associated Protein Biomarkers From Unprocessed Plasma Using an AC Electrokinetics-Based Platform.
    Hinestrosa JP; Searson DJ; Lewis JM; Kinana A; Perrera O; Dobrovolskaia I; Tran K; Turner R; Balcer HI; Clark I; Bodkin D; Hoon DSB; Krishnan R
    Front Bioeng Biotechnol; 2020; 8():581157. PubMed ID: 33224932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Dynamic ctDNA Monitoring During Combination Therapies of BRAF V600E-Mutated Metastatic Colorectal Cancer: A Case Report.
    Wang Z; Ye CY; Zhou WL; Wang MM; Dai WP; Zheng J; Zang YS
    Onco Targets Ther; 2020; 13():11849-11853. PubMed ID: 33235471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic mutational profiling of circulating tumour DNA in metastatic angiosarcoma.
    Tanaka K; Myangat TM; Sawamura S; Otsuka-Maeda S; Sakamoto R; Kanazawa-Yamada S; Kanemaru H; Makino K; Aoi J; Kajihara I; Ihn H
    J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):e293-e295. PubMed ID: 33230874
    [No Abstract]   [Full Text] [Related]  

  • 12. Bridging the age gap in breast cancer. Impacts of omission of breast cancer surgery in older women with oestrogen receptor positive early breast cancer. A risk stratified analysis of survival outcomes and quality of life.
    Wyld L; Reed MWR; Morgan J; Collins K; Ward S; Holmes GR; Bradburn M; Walters S; Burton M; Herbert E; Lifford K; Edwards A; Ring A; Robinson T; Martin C; Chater T; Pemberton K; Shrestha A; Brennan A; Cheung KL; Todd A; Audisio R; Wright J; Simcock R; Green T; Revell D; Gath J; Horgan K; Holcombe C; Winter M; Naik J; Parmeshwar R; Patnick J; Gosney M; Hatton M; Thomson AM
    Eur J Cancer; 2021 Jan; 142():48-62. PubMed ID: 33220653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive molecular profiling broadens treatment options for breast cancer patients.
    Kawaji H; Kubo M; Yamashita N; Yamamoto H; Kai M; Kajihara A; Yamada M; Kurata K; Kaneshiro K; Harada Y; Hayashi S; Shimazaki A; Mori H; Akiyoshi S; Oki E; Oda Y; Baba E; Mori M; Nakamura M
    Cancer Med; 2021 Jan; 10(2):529-539. PubMed ID: 33274848
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Lastraioli E; Antonuzzo L; Fantechi B; Di Cerbo L; Di Costanzo A; Lavacchi D; Armenio M; Arcangeli A; Castiglione F; Messerini L; Di Costanzo F
    Oncol Lett; 2021 Jan; 21(1):15. PubMed ID: 33240421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression.
    Warburton L; Calapre L; Pereira MR; Reid A; Robinson C; Amanuel B; Ziman M; Millward M; Gray E
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33238616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of
    Michaelidou K; Koutoulaki C; Mavridis K; Vorrias E; Papadaki MA; Koutsopoulos AV; Mavroudis D; Agelaki S
    Cells; 2020 Nov; 9(11):. PubMed ID: 33233668
    [No Abstract]   [Full Text] [Related]  

  • 17. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 18. Tandem reassembly of split luciferase-DNA chimeras for bioluminescent detection of attomolar circulating microRNAs using a smartphone.
    Zhou L; Zhang L; Yang L; Ni W; Li Y; Wu Y
    Biosens Bioelectron; 2021 Feb; 173():112824. PubMed ID: 33229132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Neoadjuvant-Adjuvant Treatment Strategies for Women With ERBB2 (HER2)-Positive Breast Cancer.
    Kunst N; Wang SY; Hood A; Mougalian SS; DiGiovanna MP; Adelson K; Pusztai L
    JAMA Netw Open; 2020 Nov; 3(11):e2027074. PubMed ID: 33226431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-only sequencing for oncology management: Germline-focused analysis and implications.
    George A; Turnbull C
    Genes Chromosomes Cancer; 2021 May; 60(5):352-357. PubMed ID: 33222309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.